[Correlation between fractional exhaled nitric oxide and airway reversibility in children with IgE-mediated asthma]

Xiang-Teng Liu1, Gui-Lan Wang, Jia-Yan Rong

  • 1Department of Pediatric Respiratory Medicine, Boai Hospital of Zhongshan Affiliated to Southern Medical University, Zhongshan, Guangdong 528403, China. 13924973891@139.com.

Insights

Fractional exhaled nitric oxide (FeNO) correlates with airway reversibility in children with IgE-mediated asthma, indicating its value in diagnosis and evaluation. However, FeNO is not useful for assessing airway reversibility in non-IgE-mediated asthma.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Biomarkers in Asthma

Background:

  • Asthma is a chronic respiratory disease characterized by airway inflammation.
  • Fractional exhaled nitric oxide (FeNO) is a non-invasive marker of eosinophilic airway inflammation.
  • IgE-mediated and non-IgE-mediated pathways play distinct roles in asthma pathogenesis.

Purpose of the Study:

  • To investigate the correlation between FeNO levels and airway reversibility in children with IgE-mediated asthma.
  • To compare the utility of FeNO in assessing airway reversibility between IgE-mediated and non-IgE-mediated asthma.

Main Methods:

  • A cohort of 86 children (aged 6-14) diagnosed with asthma were categorized into IgE-mediated (n=61) and non-IgE-mediated (n=25) groups.
  • FeNO measurements and pulmonary function tests (including bronchodilator response) were performed.
  • Pearson correlation analysis was employed to assess relationships between FeNO and pulmonary function parameters.

Main Results:

  • Children with IgE-mediated asthma exhibited significantly higher FeNO levels compared to the non-IgE-mediated group.
  • FeNO levels positively correlated with the number of positive specific allergens in the IgE-mediated group.
  • In IgE-mediated asthma, FeNO showed a positive correlation with changes in FEV1 and %predicted FEV1 post-bronchodilator.

Conclusions:

  • FeNO levels reflect the degree of allergic sensitization in children with asthma.
  • FeNO is a valuable tool for evaluating airway reversibility in IgE-mediated asthma.
  • FeNO is not suitable for assessing airway reversibility in non-IgE-mediated asthma, necessitating distinct management strategies.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.7K